Abstract Recent advancement in nanomedicine suggests that nanodrug delivery using nanoformulation of drugs or use of nanoparticles for neurodiagnostic and/or neurotherapeutic purposes results in superior effects than the conventional drugs or parent compounds. This indicates a bright future for nanomedicine in treating neurological diseases in clinics. However, the effects of nanoparticles per se in inducing neurotoxicology by altering amino acid neurotransmitters, if any, are still being largely ignored. The main aim of nanomedicine is to enhance the drug availability within the central nervous system (CNS) for greater therapeutic successes. However, once the drug together with nanoparticles enters into the CNS compartments, the fate of nanomaterial within the brain microenvironment is largely remained unknown. Thus, to achieve greater success in nanomedicine, our knowledge in understanding nanoneurotoxicology in detail is utmost important. In addition, how co-morbidity factors associated with neurological disease, e.g., stress, trauma, hypertension or diabetes, may influence the neurotherapeutic potentials of nanomedicine are also necessary to explore the details. Recent research in our laboratory demonstrated that engineered nanoparticles from metals or titanium nanowires used for nanodrug delivery in laboratory animals markedly influenced the CNS functions and alter amino acid neurotransmitters in healthy animals. These adverse reactions of nanoparticles within the CNS are further aggravated in animals with different co-morbidity factors viz., stress, diabetes, trauma or hypertension. This effect, however, depends on the composition and dose of the nanomaterials used. On the other hand, nanodrug delivery by TiO2 nanowires enhanced the neurotherapeutic potential of the parent compounds in CNS injuries in healthy animals and do not alter amino acids balance. However, in animals with any of the above co-morbidity factors, high dose of nanodrug delivery is needed to achieve some neuroprotection. Taken together, it appears that while exploring new nanodrug formulations for neurotherapeutic purposes, co-morbidly factors and composition of nanoparticles require more attention. Furthermore, neurotoxicity caused by nanoparticles per se following nanodrug delivery may be examined in greater detail with special regards to changes in amino acid balance in the CNS.
nanoparticles       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

laboratory animals            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Animal_testing        

laboratory                    0.9999995119964123^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Animal_testing        

co-morbidity                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Comorbidity           

nanodrug                      0.6525696908795291^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanodrug              

stress                        0.9999998128016789^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stress_(biology)      

co-morbidity                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Comorbidity           

nanomedicine                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomedicine          

nanomedicine                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomedicine          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanodrug                      0.6525696908795291^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanodrug              

hypertension                  0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hypertension          

co-morbidity                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Comorbidity           

neurotoxicology               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neurotoxin            

drugs                         0.5824921511574123^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

neurotransmitters             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neurotransmitter      

neurological diseases         0.9990995643453703^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neurological_disorder 

amino acid                    0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

nanomaterial                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomaterials         

amino acid                    0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

nanodrug                      0.6525696908795291^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanodrug              

neurotransmitters             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neurotransmitter      

titanium                      0.9985170275069286^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Titanium_dioxide      

nanodrug                      0.6525696908795291^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanodrug              

central nervous system        0.9999997603181615^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Central_nervous_system

metals                        0.9996830265586871^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Metal                 

brain                         0.9999944277663597^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

diabetes                      0.9999657924884683^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Diabetes_mellitus     

nanodrug                      0.6525696908795291^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanodrug              

microenvironment              0.9999999999990905^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Environment_(biophysical)

CNS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_nervous_system

stress                        0.9999998128016789^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stress_(biology)      

adverse reactions             0.9834804218334426^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

nanowires                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanowire              

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

amino acids                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Amino_acid            

diabetes                      0.9999657924884683^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Diabetes_mellitus     

CNS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_nervous_system

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

hypertension                  0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hypertension          

CNS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_nervous_system

nanomedicine                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomedicine          

nanowires                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanowire              

nanodrug                      0.6525696908795291^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanodrug              

nanomedicine                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomedicine          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

neurological disease          0.9999999997619398^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neurological_disorder 

trauma                        0.9995774939053093^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Trauma_(medicine)     

drug                          0.5400937420665193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

CNS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_nervous_system

neurotoxicity                 0.9999999792230485^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neurotoxicity         

TiO2                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Titanium_dioxide      

CNS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_nervous_system

drugs                         0.5824921511574123^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

CNS                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_nervous_system

amino acid                    0.9999999999997726^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

trauma                        0.9995774939053093^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Trauma_(medicine)     

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanomaterials                 0.9984057613555407^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanomaterials         

neuroprotection               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neuroprotection       

drug                          0.5400937420665193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

bright future                 0.9830709866133028^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Bright_Future         

nanomedicine                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomedicine          

